These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2544546)

  • 41. [Establishment and characterization of a tumor marker producing cell line (JR-1) derived from a gastric scirrhous cancer].
    Terano A; Nakada R; Mutoh H; Hiraishi H; Ota S; Kimura K; Aoyama H; Sugimoto T; Shiga J; Itoh Y
    Hum Cell; 1989 Sep; 2(3):307-9. PubMed ID: 2562403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].
    Huang JS
    Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of six cell lines established from human pancreatic adenocarcinomas.
    Kato M; Shimada Y; Tanaka H; Hosotani R; Ohshio G; Ishizaki K; Imamura M
    Cancer; 1999 Feb; 85(4):832-40. PubMed ID: 10091760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a newly established cell line (JR-St) derived from human gastric signet ring cell cancer, producing tumor markers.
    Terano A; Nakada R; Mutoh H; Hiraishi H; Ota S; Shiina S; Shimada T; Itoh Y; Kimura K; Shiga J
    Gastroenterol Jpn; 1991 Feb; 26(1):7-13. PubMed ID: 1848829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma.
    Haglund C; Lindgren J; Roberts PJ; Nordling S
    Br J Cancer; 1991 Mar; 63(3):386-9. PubMed ID: 1848439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishment of a human hepatic adenosquamous carcinoma cell line (KMC-2) and its response to cytokines.
    Momosaki S; Yano H; Kojiro M
    Pathol Int; 1995 Feb; 45(2):137-46. PubMed ID: 7742926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines.
    Möbus V; Gerharz CD; Press U; Moll R; Beck T; Mellin W; Pollow K; Knapstein PG; Kreienberg R
    Int J Cancer; 1992 Aug; 52(1):76-84. PubMed ID: 1500230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of HLA-DR in intrahepatic cholangiocarcinoma.
    Torii A; Harada A; Nakao A; Nonami T; Nakayama A; Ito M; Takagi H
    Cancer; 1992 Sep; 70(5):1057-61. PubMed ID: 1325267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishment and characterization of a new human lung poorly differentiated adenocarcinoma cell line, GLL-1, producing carcinoembryonic antigen (CEA) and CA19-9.
    Mitsuhashi N; Takahashi T; Sakurai H; Yamakawa M; Hasegawa M; Furuta M; Matsumoto H; Higuchi K; Hayakawa K; Niibe H
    Lung Cancer; 1995 Mar; 12(1-2):13-24. PubMed ID: 7600027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment of a new human extrahepatic bile duct carcinoma cell line (OCUCh-LM1) and experimental liver metastatic model.
    Yamada N; Chung YS; Arimoto Y; Sawada T; Seki S; Sowa M
    Br J Cancer; 1995 Mar; 71(3):543-8. PubMed ID: 7880737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment and characterization of human pancreatic adenocarcinoma cell line in tissue culture and the nude mouse.
    Kong D; Nishino N; Shibusawa M; Kusano M
    Tissue Cell; 2007 Aug; 39(4):217-23. PubMed ID: 17560620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1.
    Saijyo S; Kudo T; Suzuki M; Katayose Y; Shinoda M; Muto T; Fukuhara K; Suzuki T; Matsuno S
    Tohoku J Exp Med; 1995 Sep; 177(1):61-71. PubMed ID: 8693487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus.
    Nishihira T; Kasai M; Mori S; Watanabe T; Kuriya Y; Suda M; Kitamura M; Hirayama K; Akaishi T; Sasaki T
    Gan; 1979 Oct; 70(5):575-84. PubMed ID: 520749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment and characterization of an IGSK-2 cell line derived from ascitic fluid of recurrent hCG and somatostatin secreted adenocarcinoma of the stomach.
    Ohi S; Takahashi N; Hashimoto H; Tachibana T; Hirabayashi T; Sugiyama K; Yanaga K; Ishikawa H
    Hum Cell; 2007 May; 20(2):52-61. PubMed ID: 17547719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma.
    Gil-Benso R; Martinez-Lorente A; Pellin-Perez A; Navarro-Fos S; Gregori-Romero MA; Carda C; Callaghan R; Peydro-Olaya A; Llombart-Bosch A
    In Vitro Cell Dev Biol Anim; 2001 Jan; 37(1):17-25. PubMed ID: 11249201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
    Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
    Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma].
    Takahashi H; Miyazaki H; Deura M; Shimizu Y; Asukata I; Kameda H
    Gan No Rinsho; 1985 May; 31(6 Suppl):623-30. PubMed ID: 2411964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the exocrine pancreas.
    Okabe T; Yamaguchi N; Ohsawa N
    Cancer; 1983 Feb; 51(4):662-8. PubMed ID: 6821838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.